MICHAEL POLLAN: So this was an enormously challenging book to write. First of all, I knew very little about neuroscience. I knew very little about psychology, psychotherapy. And I had very limited experience of psychedelics. I had these mushrooms a couple of times in my 20s, but it was what people call a museum dose enough to make the world sparkle, but not to lead to any kind of profound insights. So I was faced with the challenge of mastering a new subject, and I was faced with the challenge of trying these psychedelics because I realized I could not describe the experience strictly based on interviews with other people.
And that's how I work as a writer. One of the very important parts of my work is to find a way to have an experience that will illuminate the story. So when I wrote about food, I bought a cow and followed it through the food system, through the meat industry. And I apprenticed myself to a great baker to learn how to bake. And I feel that these kind of experiences, especially when you're doing it for the first time, gives you an ability to see things very freshly. And you have that sense of wonder that comes with first sight, and you also get the common possibilities of a fish out of water, doing something that he or she is not very good at and the learning that comes from that.
So one of the things I always think about when I'm starting a project like this is, what are the different perspectives that I need to bring to bear on this subject? I don't believe any one perspective can unlock a subject as complex as psychedelics. So you need to look at it and this was true when I was writing about food and plants. Nonfiction gets interesting when you multiply the perspectives or layer the different lenses that you bring to. So you can look at this through the lens of neuroscience, say. A very interesting lens illuminates a lot.
But that doesn't tell you anything about the lived experience. Because neuroscience cannot reach consciousness. It has no tools for penetrating or measuring consciousness, except the absence of it. And so phenomenology the accounts of lived experience are very important. And I could get those from the volunteers I interviewed and from my own experience. So I needed a memoiristic element, as well as the neuroscientific element. And then there's the historical lens. History always illuminates things. How did we get here? Why did it take so long to get here? What have we learned along the way?
So I realized, O.K., I'm going to need to do a chapter of history, or two. I'm going to need to do a chapter of neuroscience, a chapter of my own trips, and it gradually comes together. Each chapter is going to represent a different lens on this subject, and I'm going to circle it from these different points of view. And that, to me, is how you make nonfiction rich. Otherwise, you might as well write an article. And what necessitates a book is the fact that no one perspective will give you the picture you need, the full dimensional picture.
Within that frame, the most challenging part was describing the psychedelic trips. And William James famously said that the mystical experience is ineffable beyond the reach of language. Well, I had an effort. I couldn't just let that lie and just say you had to be there. But it's very hard to describe because these are kind of pre-linguistic experiences.
One of the researchers I interviewed said I said why are these experiences so hard to describe? And he said, well, imagine a cave man coming to New York in 2019, and he sees subways going by, and planes overhead, and people talking on phones, and the noise of traffic. And then he goes back to his friends in the cave, and what does he say? He says it's loud and fast, and he doesn't have the words for cell phone or the bustle of urban life. The language doesn't exist.
But I had to find the language, and so I approach those chapters with a great deal of trepidation and as much trepidation as I had about the trips themselves. And it took me a while to figure out how to write about it. Because I was trying to write for a general audience. I'm not writing for psycho nuts. I'm writing for people who've never had this experience, but might be curious. And I want to tell them what it's like. And it took me a while, but I gradually found a voice in which I could do it. And this comes through trial and error of writing an account and reading it and going, that sounds crazy. Or that sounds really banal. "Gee, you've had an insight that love is the most important thing in the universe. That's a Hallmark card."
The solution I found to that was to be very candid with my reader and essentially tell the narratives. And then break the fourth wall at various points, step out of the narrative, and say, "Look, I know how banal this sounds, but let's talk about banality for a little while. There's a very thin line between the profound and the banal. What is a platitude? Well, it's a truth that's lost its emotional force from sheer repetition. So how do we recover that?" Or, in another moment, where if something crazy happens, I would break the wall and say, "I know how crazy this sounds."
So I kind of move in and out of the experience, sort of the way a memoir writer would juxtapose the point of view of the 10-year-old with the adult and go back and forth. Because if you just stayed in the head of the 10-year-old, it would have no perspective. It might have vividness, but no perspective. And if you stayed in the head of the adult, it wouldn't be evocative. So memoirs, I realized and I realized this teaching them because I teach writing get their savor or their edge from that going back and forth in perspective. And I kind of did the same thing, not in a temporal dimension, but on this inside outside of the experience.
So I found my voice to write about it, and once I did, it was great fun to write about the trips. I've never had more fun as a writer. I loved describing them. And I and I would license the absolute madness of parts of the experience by saying, "Yeah, I know, it's crazy, but this is what happened." So this book was great fun to write. I was learning new things. I loved being at the beginning of the learning curve on this subject, rather than at the end. One of the reasons I moved from writing about food to this was I realized I had become an expert after three or four books on food.
And I don't like writing as an expert. I think readers don't like experts. I think they want someone to take them on a journey. And my education becomes the story that you follow. I always start out as an idiot in my writing. I'm naive. I don't know what's going on. I'm confused. I have questions in my head. I'm reluctant. I'm skeptical. And gradually, I build my knowledge. We learn things. Things happen. And by the end, we are experts, but we're not at the beginning. And I think that's a really important lesson for writing in general.
I think even though when you finish a research project, you have your conclusions, don't put them on page one. That's like starting the joke with the punchline. Storytelling is you start from knowing less, and you move toward knowing more. So that the novelty of this subject, the fact that I was very naive, was a virtue, or at least, made a virtue. So we shouldn't be afraid of our ignorance. We should use it in our storytelling.
See the original post here:
On writing: What illuminates a story? - Big Think
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]